- Home
- RVNC vs GBAB Comparison
RVNC vs GBAB Comparison
Compare RVNC & GBAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- GBAB
- Stock Information
- Founded
- RVNC 1999
- GBAB 2010
- Country
- RVNC United States
- GBAB United States
- Employees
- RVNC N/A
- GBAB N/A
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- GBAB Investment Managers
- Sector
- RVNC Health Care
- GBAB Finance
- Exchange
- RVNC Nasdaq
- GBAB Nasdaq
- Market Cap
- RVNC 320.5M
- GBAB 381.9M
- IPO Year
- RVNC 2014
- GBAB N/A
- Fundamental
- Price
- RVNC $3.67
- GBAB $15.68
- Analyst Decision
- RVNC Hold
- GBAB
- Analyst Count
- RVNC 9
- GBAB 0
- Target Price
- RVNC $7.78
- GBAB N/A
- AVG Volume (30 Days)
- RVNC 2.9M
- GBAB 69.4K
- Earning Date
- RVNC 02-26-2025
- GBAB 01-01-0001
- Dividend Yield
- RVNC N/A
- GBAB 9.18%
- EPS Growth
- RVNC N/A
- GBAB N/A
- EPS
- RVNC N/A
- GBAB N/A
- Revenue
- RVNC $256,945,000.00
- GBAB N/A
- Revenue This Year
- RVNC $11.28
- GBAB N/A
- Revenue Next Year
- RVNC $27.21
- GBAB N/A
- P/E Ratio
- RVNC N/A
- GBAB N/A
- Revenue Growth
- RVNC 25.82
- GBAB N/A
- 52 Week Low
- RVNC $2.30
- GBAB $14.22
- 52 Week High
- RVNC $7.56
- GBAB $17.44
- Technical
- Relative Strength Index (RSI)
- RVNC 61.28
- GBAB 57.12
- Support Level
- RVNC $3.25
- GBAB $15.38
- Resistance Level
- RVNC $3.70
- GBAB $15.53
- Average True Range (ATR)
- RVNC 0.08
- GBAB 0.20
- MACD
- RVNC 0.09
- GBAB 0.06
- Stochastic Oscillator
- RVNC 95.52
- GBAB 99.31
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.
About GBAB Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust of Beneficial Interest
Guggenheim Taxable Municipal Managed Duration Trust is a diversified closed-end management investment company. Its investment objective is to provide current income with a secondary objective of long-term capital appreciation. Its products include Mutual funds, Unit investment trusts, Closed-end funds, Rydex funds, Credit income fund and others.